# Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI

> **NCT05400967** · EARLY_PHASE1 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 10 (estimated)

## Conditions studied

- 177Lu-EB-FAPI

## Interventions

- **DRUG:** 68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy

## Key facts

- **NCT ID:** NCT05400967
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05400967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05400967, "Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05400967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*